Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial

Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial

Toon andere (1) versies

Background This cost analysis uses data from a randomized trial comparing a no prophylaxis versus prophylactic platelet (PLT) transfusion policy (counts <10 × 109/L) in adult patients with hematologic malignancies.

Bibliografische gegevens
Hoofdauteurs:	Campbell, H, Estcourt, L, Stokes, E, Llewelyn, C, Murphy, M, Wood, E, Stanworth, S
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Blackwell Publishing Inc. 2014

Gelijkaardige items

Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
door: Campbell, H, et al.
Gepubliceerd in: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
door: Stanworth, S, et al.
Gepubliceerd in: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
door: Stanworth, S, et al.
Gepubliceerd in: (2014)

Prophylactic platelet transfusions
door: Estcourt, L, et al.
Gepubliceerd in: (2010)

Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
door: Stanworth, S, et al.
Gepubliceerd in: (2010)

Prophylactic platelet transfusions in patients with haematological malignancies – lessons from the TOPPS trial
door: Estcourt, L
Gepubliceerd in: (2016)

Platelet transfusions for patients with haematological malignancies: who needs them?
door: Estcourt, L, et al.
Gepubliceerd in: (2011)

Alternatives to prophylactic platelet transfusions
door: Estcourt, L
Gepubliceerd in: (2016)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
door: Desborough, M, et al.
Gepubliceerd in: (2016)

Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation
door: Estcourt, L, et al.
Gepubliceerd in: (2016)

Risk of bleeding and use of platelet transfusions in patients with hematological malignancies: recurrent event analysis
door: Stanworth, S, et al.
Gepubliceerd in: (2015)

Platelet transfusions in patients with hypoproliferative thrombocytopenia: conclusions from clinical trials and current controversies
door: Crighton, G, et al.
Gepubliceerd in: (2016)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
door: Estcourt, L, et al.
Gepubliceerd in: (2012)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions.
door: Estcourt, L, et al.
Gepubliceerd in: (2013)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions
door: Estcourt, L, et al.
Gepubliceerd in: (2013)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions
door: Estcourt, L, et al.
Gepubliceerd in: (2013)

An update on indications for platelet transfusion
door: Wood, E, et al.
Gepubliceerd in: (2016)

Prophylactic platelet transfusions.
door: Pietersz, R, et al.
Gepubliceerd in: (2012)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
door: Estcourt, L, et al.
Gepubliceerd in: (2014)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
door: Estcourt, L, et al.
Gepubliceerd in: (2014)

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
door: Stanworth, S, et al.
Gepubliceerd in: (2004)

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
door: Stanworth, S, et al.
Gepubliceerd in: (2004)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
door: Estcourt, L, et al.
Gepubliceerd in: (2015)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
door: Estcourt, L, et al.
Gepubliceerd in: (2015)

Alternatives to allogeneic platelet transfusion
door: Desborough, M, et al.
Gepubliceerd in: (2016)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
door: Estcourt, L, et al.
Gepubliceerd in: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
door: Estcourt, L, et al.
Gepubliceerd in: (2014)

Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis
door: Simon J. Stanworth, et al.
Gepubliceerd in: (2015-06-01)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
door: Estcourt, L, et al.
Gepubliceerd in: (2017)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
door: Estcourt, L, et al.
Gepubliceerd in: (2018)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
door: Crighton, GL, et al.
Gepubliceerd in: (2015)

Prophylactic platelet transfusions in critical care – how low can you go?
door: Shah, A, et al.
Gepubliceerd in: (2023)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
door: Crighton, GL, et al.
Gepubliceerd in: (2021)

Guidelines for the use of platelet transfusions
door: Estcourt, L, et al.
Gepubliceerd in: (2016)

Prophylactic plasma transfusion for patients undergoing non-cardiac surgery
door: Huber, J, et al.
Gepubliceerd in: (2017)

Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review
door: Desborough, M, et al.
Gepubliceerd in: (2016)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
door: Estcourt, L, et al.
Gepubliceerd in: (2014)

Platelet transfusion thresholds in premature neonates (PlaNeT-2 trial)
door: Estcourt, LJ
Gepubliceerd in: (2019)

A no-prophylaxis platelet-transfusion strategy for hematologic cancers.
door: Stanworth, S, et al.
Gepubliceerd in: (2013)

Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia
door: Estcourt, L, et al.
Gepubliceerd in: (2015)